124 related articles for article (PubMed ID: 16922260)
1. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.
Decker RH; Tanoue LT; Colasanto JM; Detterbeck FC; Wilson LD
Oncology (Williston Park); 2006 Jul; 20(8):899-905; discussion 905-8, 913. PubMed ID: 16922260
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.
Decker RH; Tanoue LT; Colasanto JM; Detterbeck FC; Wilson LD
Oncology (Williston Park); 2006 Jun; 20(7):727-36. PubMed ID: 16841796
[TBL] [Abstract][Full Text] [Related]
3. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
Pennathur A; Abbas G; Christie N; Landreneau R; Luketich JD
Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
[TBL] [Abstract][Full Text] [Related]
4. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
Powell JW; Dexter E; Scalzetti EM; Bogart JA
Lancet Oncol; 2009 Sep; 10(9):885-94. PubMed ID: 19717090
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
Lanuti M; Sharma A; Digumarthy SR; Wright CD; Donahue DM; Wain JC; Mathisen DJ; Shepard JA
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
8. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and treatment of high-risk patients with early-stage lung cancer.
Mehta HJ; Ross C; Silvestri GA; Decker RH
Clin Chest Med; 2011 Dec; 32(4):783-97. PubMed ID: 22054886
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
12. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
13. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies.
Williams TM; Maier A
Cancer J; 2013; 19(3):272-81. PubMed ID: 23708074
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic approaches for early stage non-small cell lung cancer.
El-Sherif A; Luketich JD; Landreneau RJ; Fernando HC
Surg Oncol; 2005 Jul; 14(1):27-32. PubMed ID: 15777887
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
17. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
[TBL] [Abstract][Full Text] [Related]
18. High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer.
Watkins JM; Wahlquist AE; Zauls AJ; Fields EC; Garrett-Mayer E; Aguero EG; Silvestri GA; Sharma AK
J Med Imaging Radiat Oncol; 2010 Dec; 54(6):554-61. PubMed ID: 21199434
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
